Plasma copper in foetal malnutrition

Area of Science:

• Neonatal Medicine
• Biochemistry
• Pediatric Nutrition

Background:

• Small for gestational age (SGA) infants represent a vulnerable population with potential nutritional challenges.
• Copper is an essential trace element crucial for fetal development and neonatal health.
• Caeruloplasmin, a major copper-binding protein, plays a role in iron metabolism and antioxidant defense.

Purpose of the Study:

• To investigate plasma copper concentrations in term infants classified as small for gestational age (SGA).
• To compare copper levels in SGA infants with appropriate for gestational age (AGA) term and preterm infants.
• To explore the potential relationship between fetal malnutrition and altered copper metabolism in SGA neonates.

Main Methods:

• Plasma copper levels were measured in cord blood samples.
• Three groups of neonates were studied: term SGA infants (n=20), term AGA infants (control, n=25), and preterm AGA infants (n=20).
• Statistical analysis was performed to compare copper concentrations between the groups.

Main Results:

• Term SGA infants exhibited significantly lower plasma copper concentrations compared to term AGA controls.
• No significant difference in plasma copper was observed between term SGA infants and preterm AGA infants.
• A notable difference in plasma copper levels was found between mothers and their neonates across all groups, attributed to higher maternal caeruloplasmin.

Conclusions:

• Reduced plasma copper in term SGA infants is likely linked to decreased liver synthesis of caeruloplasmin, potentially resulting from fetal malnutrition.
• The findings suggest impaired copper status in SGA neonates, warranting further investigation into nutritional interventions.
• Elevated maternal caeruloplasmin levels contribute to a significant fetomaternal gradient of plasma copper.